National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 22894 [05-8778]

Download as PDF 22894 Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS). Dated: April 25, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8783 Filed 5–2–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group, Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: June 7–9, 2005. Open: June 7, 2005, 6 p.m. to 6:30 p.m. Agenda: To review procedures and discuss policies. Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, San Diego, CA 92101. Closed: June 7, 2005, 6:30 p.m. to 11 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, San Diego, CA 92101. Closed: June 8, 2005, 8 a.m. to 5 p.m. VerDate jul<14>2003 15:43 May 02, 2005 Jkt 205001 Agenda: To review and evaluate grant applications. Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, San Diego, CA 92101. Closed: June 9, 2005, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, San Diego, CA 92101. Contact Person: John F. Connaughton, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 757, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7797, connaughton@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: April 25, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8778 Filed 5–2–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Deafness and Other Communications Disorders Special Emphasis Panel, Speech Processor Optimization for Cochlear Implants. Date: May 24, 2005. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Contact Person: Da-yu Wu, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd., Suite 400C, Bethesda, MD 20892, 301–496–8683, wudy@nidcd.nih.gov. Name of Committee: National Institute on Deafness and Other Communications Disorders Special Emphasis Panel, Translational Research Grants. Date: June 1, 2005. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Stanley C. Oaks, PhD., Scientific Review Administrator, Division of Extramural Activities, NIDCD, NIH, Executive Plaza South, Room 400C, 6120 Executive Blvd–MSC 7180, Bethesda, MD 20892–7180, 301–496–8683, so14s@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS.) Dated: April 25, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8782 Filed 5–2–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, ZAA1 HH (30) Fellowship Applications. Date: May 17, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 70, Number 84 (Tuesday, May 3, 2005)]
[Notices]
[Page 22894]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group, Diabetes, Endocrinology 
and Metabolic Diseases B Subcommittee.
    Date: June 7-9, 2005.
    Open: June 7, 2005, 6 p.m. to 6:30 p.m.
    Agenda: To review procedures and discuss policies.
    Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, 
San Diego, CA 92101.
    Closed: June 7, 2005, 6:30 p.m. to 11 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, 
San Diego, CA 92101.
    Closed: June 8, 2005, 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, 
San Diego, CA 92101.
    Closed: June 9, 2005, 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Wyndham San Diego at Emerald Plaza, 400 West Broadway, 
San Diego, CA 92101.
    Contact Person: John F. Connaughton, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 757, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7797, connaughton@extra.niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-8778 Filed 5-2-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.